Rashmin Savani

Company: Azome Therapeutics

Job title: Head, Scientific Advisory Board

Seminars:

Disrupting RHAMM-Target Interactions Within the NLRP3 Pathway Through Novel Peptide Inhibitors 2:30 pm

Identifying a novel downstream target of RHAMM within the NLRP3 pathway that modulates inflammatory signaling Revealing direct evidence of RHAMM’s interaction with the new target to elucidate the mechanism of this molecular engagement Demonstrating how peptide-based and small molecule inhibitors effectively block this interaction to support precise immune modulationRead more

day: Conference Day Two PM